Login to Your Account

Stimuvax Cancer Trials on Hold Due to a Case of Encephalitis

By Catherine Hollingsworth

Wednesday, March 24, 2010
Oncothyreon Inc. said that partner Merck Serono has halted clinical trials of Stimuvax after a study patient with multiple myeloma developed inflammation of the brain. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription